<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Showcasing Direct Anterior Hip Solutions at AAHKS 2024

By Lisa Mahan on 12/10/24 10:12 AM

The popularity of direct anterior approach THA is driving new product introductions.

With the exploding growth of enabling technology, much of the focus on implant solutions in recent years has been on knee replacement systems compatible with enabling technologies. At the same time, minimally invasive techniques for hip replacement using the direct anterior approach (DAA) have rapidly been gaining favor among surgeons. More companies are designing implant solutions to facilitate DAA, for use with and without enabling technologies. At this year’s American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting, manufacturers were showcasing not one, but four new hip systems specifically designed to facilitate the direct anterior approach. Because surgeon adoption of this technique appears to be accelerating, it is potentially a significant opportunity for implant companies. In a 2022 survey of its members, AAHKS found that DAA was the most utilized for primary total hip arthroplasty THA (56%), a significant increase from 2018 when 40% of AAHKS surgeons indicated they used an anterior approach.

The introduction of these new stems almost plays out like a David vs Goliath story with two smaller US market players, NextStep Arthropedix and Corin, facing two of the four largest, Zimmer Biomet and Smith+Nephew. In this downloadable article, SmartTRAK looks at these new stems hitting the US market, including a brief history of the stems, their features and benefits, and the market positioning for each.

Continue Reading
3 min read

Musculoskeletal New Ventures Conference 2024

By Erin Dorgan on 12/3/24 9:40 AM

New spine technologies "pushed the envelope" at MNVC

The Musculoskeletal New Ventures Conference (MNVC) is an annual meeting where early and late-stage companies present their ideas. This meeting occurred in Memphis, Tennessee, from October 28 - 30, with a broad mix of attendees, including surgeons, venture capitalists, the medical device industry and researchers. Forty companies presented this year, a record number for this meeting, focused exclusively on the musculoskeletal industry. In this article, SmartTRAK highlights six companies with new technologies to "push the envelope" in the US Spinal Hardware Market, which SmartTRAK estimates is growing at a 5-year CAGR of +4.7%.

This downloadable article provides an in-depth look at the following six companies' innovative new technologies:

Continue Reading
2 min read

Pioneering the Future: Inside the World's First Arthroscopic Surgical Robot

By Andy Knapik on 11/26/24 9:30 AM

Dr. Chris Jeffery, founder and CEO of Convergence Medical, discusses the V01, the world's first arthroscopic surgical robot.

In a recent interview with SmartTRAK, Dr. Chris Jeffery, the founder and CEO of Convergence Medical, discussed the V01, the world’s first dedicated arthroscopic surgical robot. In the interview, Dr. Jeffery shared insights into the V01’s novel design, business model, and technological advancements that position it as the next evolution in arthroscopic innovation. The V01 received FDA breakthrough designation in 2023 and is on track for FDA clearance and a US launch in late 2025.

Click on the following video to watch the interview (59:11 min). A complete transcript of the interview is available here. For more details, interview topics by timecode are provided below.


Interview Topics By Timecode:

  • 00:50 Dr Jeffery’s background.
  • 10:00 V01 overview.
  • 20:25 Performing a repair with the V01.
  • 26:50 V01 cost.
  • 36:10 Surgeon feedback.
  • 40:10 Importance of an arthroscopy-specific robot.
  • 42:40 Novel design of the V01.
  • 44:45 Commercial path.

Click the button below to download a complete transcript of SmartTRAK's interview with Dr. Chris Jeffrey, CEO of Convergence Medical Sciences, conducted by Andy Knapik, Senior Analyst, Soft Tissue Fixation and Arthroscopic Enabling Technologies.

Continue Reading
3 min read

Facing the Payback Crisis: Challenges Threatening Italy’s Medical Device Sector

By Anikó Szekér on 11/19/24 9:30 AM

In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at PMI Sanità, offers a comprehensive summary of the challenges for the medical device market in Italy, which places hundreds of companies at risk in the country.

Continue Reading
3 min read

SmartTRAK Expands US and Global Medtech Data Analytics Solutions Portfolio with Key Partnerships

By Linda Bernier on 11/13/24 11:25 AM

SmartTRAK’s suite of solutions for procedure and brand share analytics will provide orthopedics, wound care and neuro therapies companies with deeper market intelligence in one comprehensive platform

IRVINE, Calif.   SmartTRAK, the leading Medtech market and business intelligence solution in Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapies, announces partnerships with STATinMED, LLC and Quomeda Ltd for the development of US and global procedure tools. A third partnership with a leading healthcare insights organization will enable SmartTRAK to offer customers a brand share and price estimation tool. These new tools, combined with SmartTRAK’s highly curated content and analyst-driven insights, reduces the need for expensive, complex data sets and increases the speed for strategic decision-making.

Continue Reading
3 min read

ESMINT 2024: What's New in Neurointervention

By Anne Staylor on 11/12/24 9:30 AM

SmartTRAK reports on the latest research and innovation in neurointervention from ESMINT 2024. 

The European Society for Minimally Invasive Neurological Therapy (ESMINT) Annual Congress is unique, not only because it addresses issues and trends pertinent to Europe, but because it also provides a worldwide perspective that features cutting edge science, industry symposia, a novel “startup alley” and the latest advancements in therapies and techniques affecting the market for the minimally invasive treatment of ischemic and hemorrhagic stroke.

In this downloadable article, SmartTRAK highlights the top news, research and advances in neurointervention from ESMINT 2024 held September 4-6 in Marseille, France. This includes:

  • Innovation in Access Devices
    • Over the last several years, companies have been developing new catheters and access devices designed to better navigate difficult anatomy and tortuous vessels to reach target vessels and achieve rapid access during neurovascular intervention. With this in mind, two companies have developed novel guidewires with remotely shapeable tips that can be used to address different types of anatomy and facilitate successful catheterization ... (read more)
  • Advances in Mechanical Thrombectomy from the Following Companies
    • Rapid Medical
    • Q’Apel Medical
    • Balt
    • WallabyPhenox
    • Acandis 
    • Stryker
    • Medtronic
    • PenumbraPenumbra
    • JNJ MedTech
    • Terumo Neuro
    • Vesalio
  • Current and Emerging Flow Diverters
    • Since the FDA approved Medtronic’s Pipeline Embolization Device in 2011, flow diversion has revolutionized the treatment of intracranial aneurysms and allowed clinicians to treat a wider range of aneurysms in more complex anatomies. Today, flow diverters continue to evolve and almost every manufacturer of neurovascular devices currently has or is developing a flow diverter as part of its hemorrhagic stroke portfolio. (read more)

Click the button below to download and read the comprehensive "ESMINT 2024: What's New in Neurointervention" Market Outlook article by Anne Staylor, SmartTRAK Executive Editor VP and GM, Neuro Therapies.

Continue Reading
3 min read

Market Access: What Medtech Can Learn from Pharma

By Brad Maruca on 11/5/24 9:51 AM

Medtech companies can learn from Pharma’s evidence-based success to evolve their business strategies, expand market access and thrive.

The landscape of life sciences is profoundly shaped by the strategies companies use to gain market access. Pharma and Medtech, two principal sectors within this space, pursue markedly different paths due to their distinct business models and industry demands. Despite the differences, Medtech companies can potentially leverage strategies from Pharma to enhance their own market penetration and product success. In this article, guest writers Brad Maruca, managing director at Deloitte and former divisional vice president at Abbott Neuromodulation, along with John Jaeger, managing director at Deloitte and expert in commercial strategy, delve into the differences between these two sectors and provide a narrative outlining potential lessons Medtech might draw from Pharma's well-established market access strategies.

Among the many topics covered in detail in the complete downloadable article are:

  • Business Models and Market Strategies
    • At the core of Pharma's strategy lies a comprehensive engagement model that encompasses policy, payers, patients and clinical guidelines. This sector not only focuses on the initial market entry, but emphasizes the lifetime value of a patient, adopting an annuity model where continuous patient engagement plays a critical role in sustaining revenue. In contrast, Medtech tends to focus on innovation and physician engagement, primarily driving growth through product and procedural innovations. (read more)
  • Research & Development and Clinical Approaches
    • Pharma's approach to market access is heavily evidence-driven, relying on long-term, structured, and high-risk clinical trials to build a robust case for insurance coverage. This rigorous evidence generation ensures that once a pharmaceutical hits the market, it is backed by indisputable data that secures its place in treatment protocols. Medtech, however, often relies on shorter, iterative development cycles and may not prioritize extensive evidence generation, sometimes leading to challenges in justifying the product's efficacy and value to payers. (read more)
  • Utilizing Data and Analytics
    • While Pharma has long harnessed the power of big data and advanced analytics to inform everything from drug discovery to market penetration strategies, Medtech has been slower in adopting these resources to their full potential. (read more)
  • Collaboration and Pricing Strategies
    • Pharma's widespread collaborations with stakeholders across the spectrum—from healthcare providers to research institutions—have fortified its market access strategies. Medtech’s collaborations, though robust with hospitals and clinicians, often miss the broader stakeholder engagement that could drive policy and guideline development. (read more)

Click the button below to download and read the complete "Market Access: What Medtech Can Learn from Pharma" perspective article written by guest writers Brad Maruca, managing director at Deloitte and former divisional VP at Abbott Neuromodulation, and John Jaeger, managing director at Deloitte and an expert in commercial strategy, 

Topics: Medtech
Continue Reading
3 min read

NASS 2024: Enabling Tech Still Making Waves

By Elise Wolf on 10/29/24 9:30 AM

Technological advances, new market entrants and novel technology continue to make waves at NASS 2024.

SmartTRAK attended this year’s 39th Annual North American Spine Society (NASS) meeting in Chicago, IL, which took place September 25-28, 2024. With the attendance of industry professionals rivaling that of surgeons at this year’s meeting, enabling technology continued to make waves on the exhibit floor yet again. The ongoing focus on enabling tech is not surprising given that robotics and navigation platforms have continued to support Spine Hardware Market growth in recent years. To date in 2024, SmartTRAK estimates that the Enabling Tech Market for Robotics and Navigation has increased at near double-digits (+9.6% growth) YoY through Q224, according to SmartTRAK Financial Dashboard

Among the many topics discussed in this article are:

  • Robot Wars Heating Up in Spine
    • Robotics were on display from market leaders Medtronic (MDT) and Globus Medical (GMED) at NASS 2024. MDT announced new advancements in its AiBLE ecosystem including ... (read more)
  • Augmented/Mixed Reality on Display
    • Augmented reality-based navigation solutions were also showcased at the meeting. At NASS 2024, SmartTRAK learned that the Augmedics xvision augmented-reality based intraoperative navigation system has been used to treat ... (read more)
  • Novel Handheld Navigation Designed to Overcome Challenges
    • In a NASS 2024 Symposium entitled “The Symbiosis of Robotics, Enabling Technology and Minimally Invasive Surgery,” panelists mentioned that one limitation of many robotic and navigation systems is ... (read more)
  • Ongoing Technological Advances
    • With increasing adoption of enabling technologies and a growing level of experience in using them in spine procedures comes a better understanding of the advantages and limitations of current assistive technology solutions. Companies across the industry from large strategics to small start-ups are continuing to make ... (read more)

Click the button below to download and read the complete "NASS 2024: Enabling Tech Still Making Waves" market perspective article by Elise Wolf, GM & VP, SmartTRAK Orthopedics & Quality.

Continue Reading
2 min read

Plastic Surgery The Meeting 2024: The Latest Research and Trends

By Doug Devens on 10/22/24 9:30 AM

SmartTRAK reports on the latest research and product trends that could potentially impact the market at PSTM 2024.

Advancements in the US Breast Matrices Market continue to unfold as companies work to build the knowledge base about recently introduced biosynthetic breast matrices to help surgeons optimize long-term outcomes and improve the standard of care. At this year’s Plastic Surgery The Meeting (PSTM 24), held September 26-29 in San Diego, California, SmartTRAK identified several research and product trends that could potentially impact the US Breast Matrices Market, particularly in biosynthetic breast matrices. This includes a growing interest in new biosynthetic materials, focusing on long-term aesthetic results, expanding into new indications and using biosynthetics in breast reconstruction.

Among the topics discussed in this informative perspective article are:

  • New Materials and Products Driving Growth in Biosynthetics
    • According to SmartTRAK, the US Breast Matrices Market will achieve a projected CAGR of +3.5%. However, resorbable biosynthetic matrices are projected to grow ... (read more)
  • Focusing on Long-Term Results, Expanded Indications
    • At the meeting, several presenters focused on improving the reliability of long-term aesthetic results for cosmetic and reconstructive breast surgery and using biosynthetics in expanded indications ... (read more)
  • Using Biosynthetics in Breast Reconstruction
    • Making the transition from use in cosmetic surgeries to breast reconstruction is the goal of Integra and BD. Breast reconstruction accounts for 93% of the US Breast Matrices market, primarily because insurance reimbursements remove ... (read more)

Click the button below to download and read the complete "PSTM 2024 Annual Meeting Highlights" perspective article by Doug Devens. SmartTRAK Sr. Product Director/Sr. Analyst - Wound.

Continue Reading
2 min read

NASS 2024: Highlights from the Annual Meeting in Chicago

By Erin Dorgan on 10/15/24 9:30 AM

New products and clinical data continue to grow the spinal hardware and bone replacement markets.

The North American Spine Society (NASS) was buzzing with new technologies at its 39th annual meeting in Chicago, September 25-28. Over 4,000 medical registrants and industry personnel attended this year’s meeting. This is the largest spine-focused meeting in the US, and it supports the spinal hardware and bone replacement markets. SmartTRAK estimates the spinal hardware market is poised to post a 5-yr CAGR of +4.7%, and the bone replacement market in spine is expected to reach a 5-year CAGR of +3.5%.

In this market perspective article, SmartTRAK highlights ...

  • Spine Hardware Refreshed-The Latest Product Innovations
    • Pedicle Screws
    • Disc Prep
  • Bone Replacement Market - New Products for DBM
    • The Data Race Continues
    • Product Innovations
  • A Strong Showing from Korean Manufacturers
    • New this year at NASS was the Korean SpineTech Pavilion, sponsored by the Korean Ministry of Health and Welfare and the Korean Health Industry Development Institute. This pavilion housed smaller companies at one booth to showcase ...

Click the button below to download and read the complete "NASS 2024 Annual Meeting Highlights" market perspective article by Erin Dorgan, SmartTRAK Senior Analyst, Spine.

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles